Clinical and Translational Science Collaborative offering funding for pilot awards; letters of intent due Nov. 15

The Clinical and Translational Science Collaborative Annual Pilot Award Program is seeking letters of intent for one-year Annual Pilot Projects ($50,000) for:

  • Dissemination and implementation of research evidence and innovation to clinical practice; and
  • Interventions at community and/or clinical practices to promote health equity.

Later stages of Translational Research (T3/T4) are the target for this year’s program. One-page letters of intent (LOI) are due Nov. 15 at 11:59 p.m. via InfoReady.

Applicants will submit a letter of intent to clearly enunciate the proposed activities that address one or more of these goals with a sustainable design for future application to community health. Applicants submitting a successful LOI will be invited to submit a full proposal.

A minimum of two, and up to six grants, will be awarded with budgets of up to $50,000 each in direct costs. All research activities must be completed by June 30, 2025.

The ideal letter of intent will address a later stage of clinical research (T3/T4) of community health with an articulated, quantitative outcome result leading to a change in health using translational research approaches. Examples that will be more favorably reviewed are projects that:

  • Build teams across biological and behavioral methodology and clinical health science;
  • Articulate the innovation for the applicant and/or the co-investigator(s);
  • Use community engagement principles to address equity in deployment of the outcomes;
  • Show incremental impact, if any, of a novel strategy to improve health in special populations (e.g. children, minorities, handicapped, elderly, vulnerable, etc.).

View the call for letters of intent and the full 2024 request for applications.

Questions? Contact Wesley Chen, pilot coordinator, at